Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats

Neuroscience

Volumn 236, Issue , 2013, Pages 298-312

  Serova, L I ^a   Tillinger, A ^a   Alaluf, L G ^a   Laukova, M ^a   Keegan, K ^a   Sabban, E L ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Glucocorticoid receptor; HPA axis; Intranasal neuropeptide Y administration; Locus coeruleus; Single prolonged stress; TH mRNA

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y; TYROSINE 3 MONOOXYGENASE;

ACOUSTIC STARTLE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; ELEVATED PLUS MAZE TEST; ENZYME INDUCTION; FORCED SWIM TEST; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCUS CERULEUS; MALE; MENTAL STRESS; NON INVASIVE PROCEDURE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RAT; STARTLE REFLEX; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRANASAL DRUG ADMINISTRATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BLOTTING, WESTERN; CORTICOSTERONE; DISEASE MODELS, ANIMAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STARTLE REACTION; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL;

EID: 84882962236     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.040     Document Type: Article

References (109)

1. Aston-Jones G., Rajkowski J., Kubiak P., Valentino R.J., Shipley M.T. Role of the locus coeruleus in emotional activation. Prog Brain Res 1996, 107:379-402.
2. Augustsson H., Dahlborn K., Meyerson B.J. Exploration and risk assessment in female wild house mice (Mus musculus musculus) and two laboratory strains. Physiol Behav 2005, 84:265-277.
3. Baker D.G., Nievergelt C.M., Risbrough V.B. Post-traumatic stress disorder: emerging concepts of pharmacotherapy. Expert Opin Emerg Drugs 2009, 14:251-272.
4. Baltatzi M., Hatzitolios A., Tziomalos K., Iliadis F., Zamboulis C. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Int J Clin Pract 2008, 62:1432-1440.
5. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., McCaleb M.L. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 2000, 868:79-87.
6. Blakemore L.J., Levenson C.W., Trombley P.Q. Neuropeptide Y modulates excitatory synaptic transmission in the olfactory bulb. Neuroscience 2006, 138:663-674.
7. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002, 5:514-516.
8. Bowirrat A., Chen T.J., Blum K., Madigan M., Bailey J.A., Chuan Chen A.L., Downs B.W., Braverman E.R., Radi S., Waite R.L., Kerner M., Giordano J., Morse S., Oscar-Berman M., Gold M. Neuro-psychopharmacogenetics and neurological antecedents of posttraumatic stress disorder: unlocking the mysteries of resilience and vulnerability. Curr Neuropharmacol 2010, 8:335-358.
9. Campbell D.G., Felker B.L., Liu C.F., Yano E.M., Kirchner J.E., Chan D., Rubenstein L.V., Chaney E.F. Prevalence of depression-PTSD comorbidity: implications for clinical practice guidelines and primary care-based interventions. J Gen Intern Med 2007, 22:711-718.
10. Cohen H., Liu T., Kozlovsky N., Kaplan Z., Zohar J., Mathé A.A. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 2012, 37:350-363.
11. Cohen H., Matar M.A., Buskila D., Kaplan Z., Zohar J. Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder. Biol Psychiatry 2008, 64:708-717.
12. Costantino H.R., Illum L., Brandt G., Johnson P.H., Quay S.C. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 2007, 337:1-24.
13. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
14. de Kloet E.R., Joëls M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005, 6:463-475.
15. Dhuria S.V., Hanson L.R., Frey W.H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 2010, 99:1654-1673.
16. Eaton K., Sallee F.R., Sah R. Relevance of neuropeptide Y (NPY) in psychiatry. Curr Top Med Chem 2007, 7:1645-1659.
17. Edvinsson L., Ekblad E., Håkanson R., Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 1984, 83:519-525.
18. Elzinga B.M., Schmahl C.G., Vermetten E., van Dyck R., Bremner J.D. Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology 2003, 28:1656-1665.
19. Fehm H.L., Perras B., Smolnik R., Kern W., Born J. Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?. Eur J Pharmacol 2000, 405:43-54.
20. Finta E.P., Regenold J.T., Illes P. Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones. Naunyn Schmiedebergs Arch Pharmacol 1992, 346:472-474.
21. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol Rev 1983, 63:844-914.
22. Geyer M., Swerdlow N. Measurement of startle response, prepulse inhibition and habituation. Current protocols in neuroscience 1998, 8.7.1-8.7.15. John Wiley & Sons, Inc.
23. Gutman A.R., Yang Y., Ressler K.J., Davis M. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci 2008, 28:12682-12690.
24. Hebert M.A., Serova L.I., Sabban E.L. Single and repeated immobilization stress differentially trigger induction and phosphorylation of several transcription factors and mitogen-activated protein kinases in the rat locus coeruleus. J Neurochem 2005, 95:484-498.
25. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
26. Heilig M., Söderpalm B., Engel J.A., Widerlöv E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl) 1989, 98:524-529.
27. Heilig M., Widerlöv E. Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses. Acta Psychiatr Scand 1990, 82:95-114.
28. Hirsch D., Zukowska Z. NPY and stress 30 years later: the peripheral view. Cell Mol Neurobiol 2012, 32:645-659.
29. Hou C., Jia F., Liu Y., Li L. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res 2006, 1095:154-158.
30. Illes P., Finta E.P., Nieber K. Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones. Naunyn Schmiedebergs Arch Pharmacol 1993, 348:546-548.
31. Ionescu I.A., Dine J., Yen Y.C., Buell D.R., Herrmann L., Holsboer F., Eder M., Landgraf R., Schmidt U. Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons. Neuropsychopharmacology 2012, 37:1323-1337.
32. Kar N. Cognitive behavioral therapy for the treatment of post-traumatic stress disorder: a review. Neuropsychiatr Dis Treat 2011, 7:167-181.
33. Karlsson R.M., Holmes A., Heilig M., Crawley J.N. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav 2005, 80:427-436.
34. Kask A., Harro J., von Horsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 2002, 26:259-283.
35. Kask A., Harro J., von Hörsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 2002, 26:259-283.
36. Kask A., Rägo L., Harro J. Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res 1998, 788:345-348.
37. Kastin A.J., Akerstrom V. Nonsaturable entry of neuropeptide Y into brain. Am J Physiol 1999, 276:E479-E482.
38. Kessler R.C. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry 2000, 61(Suppl. 5):4-12. (discussion 13-14).
39. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995, 52:1048-1060.
40. Khan S., Liberzon I. Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychopharmacology (Berl) 2004, 172:225-229.
41. Knox D., Perrine S.A., George S.A., Galloway M.P., Liberzon I. Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex. Neurosci Lett 2010, 480:16-20.
42. Kohda K., Harada K., Kato K., Hoshino A., Motohashi J., Yamaji T., Morinobu S., Matsuoka N., Kato N. Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model. Neuroscience 2007, 148:22-33.
43. Kozlovsky N., Matar M.A., Kaplan Z., Zohar J., Cohen H. A distinct pattern of intracellular glucocorticoid-related responses is associated with extreme behavioral response to stress in an animal model of post-traumatic stress disorder. Eur Neuropsychopharmacol 2009, 19:759-771.
44. Kvetnansky R., Mikulaj L. Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress. Endocrinology 1970, 87:738-743.
45. Kvetnansky R., Sabban E.L., Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 2009, 89:535-606.
46. Lapiz-Bluhm M.D., Bondi C.O., Doyen J., Rodriguez G.A., Bedard-Arana T., Morilak D.A. Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J Neuroendocrinol 2008, 20:1115-1137.
47. Li M., Han F., Shi Y. Expression of locus coeruleus mineralocorticoid receptor and glucocorticoid receptor in rats under single-prolonged stress. Neurol Sci 2011, 32:625-631.
48. Liberzon I., Abelson J.L., Flagel S.B., Raz J., Young E.A. Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 1999, 21:40-50.
49. Liberzon I., Krstov M., Young E.A. Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 1997, 22:443-453.
50. Liberzon I., López J.F., Flagel S.B., Vázquez D.M., Young E.A. Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder. J Neuroendocrinol 1999, 11:11-17.
51. Liberzon I., Sripada C.S. The functional neuroanatomy of PTSD: a critical review. Prog Brain Res 2008, 167:151-169.
52. Liposits Z., Sievers L., Paul W.K. Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry 1988, 88:227-234.
53. Liu X., Kvetnansky R., Serova L., Sollas A., Sabban E.L. Increased susceptibility to transcriptional changes with novel stressor in adrenal medulla of rats exposed to prolonged cold stress. Brain Res Mol Brain Res 2005, 141:19-29.
54. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
55. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009, 10:434-445.
56. McEwen B.S., Eiland L., Hunter R.G., Miller M.M. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012, 62:3-12.
57. Melia K.R., Nestler E.J., Duman R.S. Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats. Psychopharmacology (Berl) 1992, 108:23-26.
58. Morales-Medina J.C., Dumont Y., Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Res 2010, 1314:194-205.
59. Nankova B., Kvetnansky R., McMahon A., Viskupic E., Hiremagalur B., Frankle G., Fukuhara K., Kopin I.J., Sabban E.L. Induction of tyrosine hydroxylase gene expression by a nonneuronal nonpituitary-mediated mechanism in immobilization stress. Proc Natl Acad Sci U S A 1994, 91:5937-5941.
60. Nilsson C., Karlsson G., Blennow K., Heilig M., Ekman R. Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients. Peptides 1996, 17:359-362.
61. O'Donnell T., Hegadoren K.M., Coupland N.C. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology 2004, 50:273-283.
62. Olson V.G., Rockett H.R., Reh R.K., Redila V.A., Tran P.M., Venkov H.A., Defino M.C., Hague C., Peskind E.R., Szot P., Raskind M.A. The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder. Biol Psychiatry 2011, 70:441-448.
63. Palkovits M. Stress-induced activation of neurons in the ventromedial arcuate nucleus: a blood-brain-CSF interface of the hypothalamus. Ann N Y Acad Sci 2008, 1148:57-63.
64. Paxinos G., Watson C. The rat brain in sterotaxic coordinates 1998, Academic Press, San Diego.
65. Pervanidou P., Chrousos G.P. Neuroendocrinology of post-traumatic stress disorder. Prog Brain Res 2010, 182:149-160.
66. Pitman R.K., Rasmusson A.M., Koenen K.C., Shin L.M., Orr S.P., Gilbertson M.W., Milad M.R., Liberzon I. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci 2012, 13:769-787.
67. Primeaux S.D., Wilson S.P., Cusick M.C., York D.A., Wilson M.A. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 2005, 30:1589-1597.
68. Rasmusson A.M., Hauger R.L., Morgan C.A., Bremner J.D., Charney D.S., Southwick S.M. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 2000, 47:526-539.
69. Redrobe J.P., Dumont Y., Fournier A., Quirion R. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 2002, 26:615-624.
70. Ruohonen S.T., Savontaus E., Rinne P., Rosmaninho-Salgado J., Cavadas C., Ruskoaho H., Koulu M., Pesonen U. Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons. Neuroendocrinology 2009, 89:351-360.
71. Sabban E.L., Kvetnansky R. Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends Neurosci 2001, 24:91-98.
72. Sabban E.L., Maharjan S., Nostramo R., Serova L.I. Divergent effects of estradiol on gene expression of catecholamine biosynthetic enzymes. Physiol Behav 2010, 99:163-168.
73. Saegusa Y., Takeda H., Muto S., Nakagawa K., Ohnishi S., Sadakane C., Nahata M., Hattori T., Asaka M. Decreased plasma ghrelin contributes to anorexia following novelty stress. Am J Physiol Endocrinol Metab 2011, 301:E685-E696.
74. Sah R., Ekhator N.N., Strawn J.R., Sallee F.R., Baker D.G., Horn P.S., Geracioti T.D. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry 2009, 66:705-707.
75. Sah R., Geracioti T.D. Neuropeptide Y and posttraumatic stress disorder. Mol Psychiatry 2012, 10.1038/mp.2012.101.
76. Sajdyk T.J., Schober D.A., Gehlert D.R. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 2002, 43:1165-1172.
77. Sajdyk T.J., Schober D.A., Smiley D.L., Gehlert D.R. Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 2002, 71:419-423.
78. Scherer I.J., Holmes P.V., Harris R.B. The importance of corticosterone in mediating restraint-induced weight loss in rats. Physiol Behav 2011, 102:225-233.
79. Schmidt M.V., Liebl C., Sterlemann V., Ganea K., Hartmann J., Harbich D., Alam S., Müller M.B. Neuropeptide Y mediates the initial hypothalamic-pituitary-adrenal response to maternal separation in the neonatal mouse. J Endocrinol 2008, 197:421-427.
80. Serova L., Danailov E., Chamas F., Sabban E.L. Nicotine infusion modulates immobilization stress-triggered induction of gene expression of rat catecholamine biosynthetic enzymes. J Pharmacol Exp Ther 1999, 291:884-892.
81. Serova L.I., Gueorguiev V., Cheng S.Y., Sabban E.L. Adrenocorticotropic hormone elevates gene expression for catecholamine biosynthesis in rat superior cervical ganglia and locus coeruleus by an adrenal independent mechanism. Neuroscience 2008, 153:1380-1389.
82. Serova L.I., Nankova B.B., Feng Z., Hong J.S., Hutt M., Sabban E.L. Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress. Biol Psychiatry 1999, 45:853-862.
83. Shalev A.Y., Peri T., Brandes D., Freedman S., Orr S.P., Pitman R.K. Auditory startle response in trauma survivors with posttraumatic stress disorder: a prospective study. Am J Psychiatry 2000, 157:255-261.
84. Shalev A.Y., Videlock E.J., Peleg T., Segman R., Pitman R.K., Yehuda R. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part I: HPA axis responses. Int J Neuropsychopharmacol 2008, 11:365-372.
85. Skelton K., Ressler K.J., Norrholm S.D., Jovanovic T., Bradley-Davino B. PTSD and gene variants: new pathways and new thinking. Neuropharmacology 2012, 62:628-637.
86. Smith K.M., Mitchell S.N., Joseph M.H. Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J Neurochem 1991, 57:1750-1756.
87. Sones H.M., Thorp S.R., Raskind M. Prevention of posttraumatic stress disorder. Psychiatr Clin North Am 2011, 34:79-94.
88. Southwick S.M., Bremner J.D., Rasmusson A., Morgan C.A., Arnsten A., Charney D.S. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 1999, 46:1192-1204.
89. Stogner K.A., Holmes P.V. Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 2000, 387:R9-R10.
90. Strawn J.R., Geracioti T.D. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety 2008, 25:260-271.
91. Thorne R.G., Emory C.R., Ala T.A., Frey W.H. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res 1995, 692:278-282.
92. Thorne R.G., Pronk G.J., Padmanabhan V., Frey W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004, 127:481-496.
93. Thorsell A. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp Biol Med (Maywood) 2010, 235:1163-1167.
94. Tovote P., Meyer M., Beck-Sickinger A.G., von Horsten S., Ove Ogren S., Spiess J., Stiedl O. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue. Regul Pept 2004, 120:205-214.
95. Ulrich-Lai Y.M., Figueiredo H.F., Ostrander M.M., Choi D.C., Engeland W.C., Herman J. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab 2006, 291:E96-E973.
96. Valentino R.J., Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 2008, 583:194-203.
97. Videlock E.J., Peleg T., Segman R., Yehuda R., Pitman R.K., Shalev A.Y. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part II: the adrenergic response. Int J Neuropsychopharmacol 2008, 11:373-380.
98. Wang D., Noda Y., Tsunekawa H., Zhou Y., Miyazaki M., Senzaki K., Nabeshima T. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav Brain Res 2007, 178:262-273.
99. Wu G., Feder A., Wegener G., Bailey C., Saxena S., Charney D., Mathé A.A. Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 2011, 15:1317-1331.
100. Yamamoto S., Morinobu S., Takei S., Fuchikami M., Matsuki A., Yamawaki S., Liberzon I. Single prolonged stress: toward an animal model of posttraumatic stress disorder. Depress Anxiety 2009, 26:1110-1117.
101. Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am 2002, 25:341-368. vii.
102. Yehuda R. Neuroendocrine aspects of PTSD. Handb Exp Pharmacol 2005, 169:371-403.
103. Yehuda R., Brand S., Yang R.K. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry 2006, 59:660-663.
104. Yehuda R., Giller E.L., Southwick S.M., Lowy M.T., Mason J.W. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 1991, 30:1031-1048.
105. Yehuda R., LeDoux J. Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron 2007, 56:19-32.
106. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am J Psychiatry 1991, 148:499-504.
107. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.
108. Zohar J., Yahalom H., Kozlovsky N., Cwikel-Hamzany S., Matar M.A., Kaplan Z., Yehuda R., Cohen H. High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies. Eur Neuropsychopharmacol 2011, 21:796-809.
109. Zukowska-Grojec Z. Neuropeptide Y: a novel sympathetic stress hormone and more. Ann N Y Acad Sci 1995, 771:219-233.